Abstract
The retinoblastoma family members – pRb, pRb2/p130 and p107 – are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- IHC:
-
immunohistochemistry
- LOH:
-
loss of heterozygosity
References
Baldi A, Esposito V, De Luca A, Howard CM, Mazzarella G, Baldi F et al. (1996). Clin Cancer Res 2: 1239–1245.
Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG et al. (1997). Clin Cancer Res 3: 1691–1697.
Barrett MT, Galipeau PC, Sanchez CA, Edmond MJ, Reid BJ . (1996). Oncogene 12: 1873–1878.
Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J et al. (1996). Cancer Res 56: 5475–5483.
Benassi MS, Molendini L, Gamberi G, Ragazzini P, Sollazzo MR, Merli M et al. (1999). Int J Cancer 84: 489–493.
Bianchi S, Calzolari A, Giannelli E, Giordano A, Zampi G . (1994). Pathologica 86: 146–149.
Bieche I, Lidereau R . (2000). Mol Carcinogen 29: 151–158.
Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C . (1990). N Engl J Med 323: 1457–1462.
Ceccarelli C, Santini D, Chieco P, Taffurelli M, Gamberini M, Pileri SA et al. (1998). J Clin Pathol 51: 818–824.
Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M et al. (2003). J Clin Oncol 17: 3328–3334.
Chan MK, Cheung TH, Chung TK, Bao SY, Zhao CL, Nobori T et al. (1998). Gynecol Oncol 68: 156–161.
Chen JT, Chen YC, Chen CY, Wang YC . (2001). Lung Cancer 31: 163–170.
Cinti C, Leoncini L, Nyongo A, Ferrari F, Lazzi S, Bellan C et al. (2000). Am J Pathol 156: 751–760.
Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. (1994). Cancer Res 54: 5556–5560.
Claudio PP, Howard CM, Fu Y, Cinti C, Califano L, Micheli P et al. (2000a). Cancer Res 60: 8–12.
Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C et al. (2000b). Cancer Res 60: 372–382.
Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A et al. (2002). Clin Cancer Res 8: 1808–1815.
Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S et al. (2004). Clin Cancer Res 10: 3509–3517.
Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z et al. (1992). J Natl Cancer Inst 84: 1251–1256.
Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC et al. (1998). Cancer Res 58: 1090–1094.
Cui X, Shirai Y, Wakai T, Yokoyama N, Hirano S, Hatakeyama K . (2004). Hum Pathol 35: 1189–1195.
D’Andrilli G, Masciullo V, Bagella L, Tonini T, Minimo C, Zannoni GF et al. (2004). Clin Cancer Res 10: 3098–3103.
De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P et al. (1997). Nat Med 3: 913–916.
Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL et al. (1994). Cancer Res 54: 610–613.
Dokiya F, Ueno K, Ma S, Eizuru Y, Furuta S, Ohyama M . (1998). Acta Otolaryngol 118: 759–762.
Dong Y, Walsh MD, McGuckin MA, Cummings MC, Gabrielli BG, Wright GR et al. (1997). Int J Cancer 74: 407–415.
Feakins RM, Nickols CD, Bidd H, Walton SJ . (2003). Hum Pathol 34: 1276–1282.
Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S et al. (1996). J Clin Oncol 14: 467–472.
Fung YK, T’Ang A . (1992). Cancer Treat Res 61: 59–68.
Geradts J, Hu SX, Lincoln CE, Benedict WF, Xu HJ . (1994). Int J Cancer 58: 161–167.
Girod SC, Pfeiffer P, Ries J, Pape HD . (1998). Br J Oral Maxillofac Surg 36: 252–260.
Goldstein NS . (2000). Ann Thorac Surg 69: 1648–1649.
Guenova M, Rassidakis GZ, Gorgoulis VG, Angelopoulou MK, Siakantaris MR, Kanavaros P et al. (1999). Mod Pathol 12: 1062–1071.
Hashiguchi Y, Tsuda H, Inoue T, Nishimura S, Suzuki T, Kawamura N . (2004). Hum Pathol 35: 165–175.
Helin K, Holm K, Niebuhr A, Eiberg H, Tommerup N, Hougaard S et al. (1997). Proc Natl Acad Sci USA 94: 6933–6938.
Hensel CH, Hsieh CL, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL et al. (1990). Cancer Res 50: 3067–3072.
Hommura F, Dosaka-Akita H, Kinoshita I, Mishina T, Hiroumi H, Ogura S et al. (1999). Br J Cancer 81: 696–701.
Hui AM, Li X, Makuuchi M, Takayama T, Kubota K . (1999). Int J Cancer 84: 604–608.
Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N . (2000). J Surg Oncol 73: 104–108.
Ishii H, Igarashi T, Saito T, Nakano T, Mori M, Ohyama H et al. (1997). Am J Hematol 55: 46–48.
Jahnson S, Karlsson MG . (1998). J Urol 160: 1291–1296.
Karpeh MS, Brennan MF, Cance WG, Woodruff JM, Pollack D, Casper ES et al. (1995). Br J Cancer 72: 986–991.
Kim TM, Benedict WF, Xu HJ, Hu SX, Gosewehr J, Velicescu M et al. (1994). Cancer Res 54: 605–609.
Kusume T, Tsuda H, Kawabata M, Inoue T, Umesaki N, Suzuki T et al. (1999). Clin Cancer Res 5: 4152–4157.
Laupacis A, Wells G, Richardson WS, Tugwell P . (1994). JAMA 272: 234–237.
Li W, Fan J, Hochhauser D, Banerjee D, Zielinski Z, Almasan A et al. (1995). Proc Natl Acad Sci USA 92: 10436–10440.
Liu Y, Heyman M, Wang Y, Falkmer U, Hising C, Szekely L et al. (1994). Int J Cancer 58: 663–667.
Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sabin A, Ordonez N et al. (1992). J Natl Cancer Inst 84: 1256–1261.
Macaluso M, Cinti C, Russo G, Russo A, Giordano A . (2003). Oncogene 22: 3511–3517.
Masciullo V, Khalili K, Giordano A . (2000). Int J Oncol 17: 897–902.
Massaro-Giordano M, Baldi G, De Luca A, Baldi A, Giordano A . (1999). Clin Cancer Res 5: 1455–1458.
Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger AM, Loning T . (2001). Br J Cancer 85: 546–551.
Milde-Langosch K, Hagen M, Bamberger AM, Loning T . (2003). Int J Gynecol Pathol 22: 168–174.
Minimo C, Bibbo M, Claudio PP, De Luca A, Giordano A . (1999). Pathol Res Pract 195: 67–70.
Mizokami H, Sawatsubashi M, Tokunaga O, Shin T . (1999). Mod Pathol 12: 47–53.
Morente MM, Piris MA, Abraira V, Acevedo A, Aguilera B, Bellas C et al. (1997). Blood 90: 2429–2436.
Munger K, Scheffner M, Huibregtse JM, Howley PM . (1992). Cancer Surv 12: 197–217.
Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y, Matsumura T . (2000). Cancer Lett 160: 3–8.
Omura K, Nagasato A, Kanehira E, Kinsen H, Amaya S, Kimura K et al. (1997). J Clin Oncol 15: 3458–3463.
Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K . (1995). Eur J Cancer 31A: 329–333.
Pinto AE, Andre S, Laranjeira C, Soares J . (2005). Pathology 37: 45–50.
Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnel TJ . (1997). Clin Cancer Res 13: 1823–1829.
Poller DN, Baxter KJ, Shepherd NA . (1997). Br J Cancer 75: 87–93.
Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP et al. (2000). Int J Oncol 17: 963–969.
Rolfe KJ, Crow JC, Benjamin E, Reid WM, Maclean AB, Perrett CW . (2001). Int J Gynecol Cancer 11: 381–386.
Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G et al. (2005). Clin Cancer Res 11: 3265–3273.
Salgia R, Skarin AT . (1998). J Clin Oncol 16: 1207–1217.
Sanchez E, Chacon I, Plaza MM, Munoz E, Cruz MA, Martinez B et al. (1998). J Clin Oncol 16: 1931–1939.
Sartor M, Steingrimsdottir H, Elamin F, Gaken J, Warnakulasuriya S, Partridge M et al. (1999). Br J Cancer 80: 79–86.
Sawan A, Randall B, Angus B, Wright C, Henry JA, Ostrowski J et al. (1992). J Pathol 168: 23–28.
Schemper M . (1993). Stat Med 12: 2377–2382.
Semczuk A, Schneider-Stock R, Miturski R, Skomra D, Tomaszewski J, Roessner A et al. (2000). Pathol Res Pract 196: 41–46.
Skomedal H, Kristensen GB, Lie AK, Holm R . (1999). Gynecol Oncol 73: 223–228.
Song HS, Kim IH, Sohn SS, Kwon KY, Lee WS . (2005). Korean J Intern Med 20: 1–7.
Spandidos DA, Karaiossifidi H, Malliri A, Linardopoulos S, Vassilaros S, Tsikkinis A et al. (1992). Anticancer Res 12: 81–89.
Sun Y, Hegamyer G, Colburn NH . (1993). Oncogene 8: 791–795.
Susini T, Baldi F, Howard CM, Baldi A, Taddei G, Massi D et al. (1998). J Clin Oncol 16: 1085–1093.
Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A et al. (2001). Hum Pathol 32: 360–367.
Tonini T, Gabellini C, Bagella L, D’Andrilli G, Masciullo V, Romano G et al. (2004). Clin Cancer Res 10: 8085–8093.
Trudel M, Mulligan L, Cavenee W, Margolese R, Cote J, Gariepy G . (1992). Hum Pathol 23: 1388–1394.
Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y et al. (1994). Cancer Res 54: 3042–3048.
Wakasugi E, Kobayashi T, Tamaki Y, Nakano Y, Ito Y, Miyashiro I et al. (1997). J Clin Pathol 50: 407–412.
Walther MM, Gnarra JR, Elwood L, Xu HJ, Florence C, Anglard P et al. (1995). J Urol 153: 2050–2054.
Weide R, Tiemann M, Pfluger KH, Koppler H, Parvizl B, Wacker HH et al. (1994). Leukemia 8: 97–101.
Wrede D, Tidy JA, Crook T, Lane D, Vousden KH . (1991). Mol Carcinogen 4: 171–175.
Wurl P, Meye A, Berger D, Lautenschlager C, Bache M, Holzhausen HJ et al. (1998). Langenbecks Arch Surg 383: 99–103.
Wurl P, Meye A, Lautenschlager C, Schmidt H, Bache M, Kalthoff H et al. (1999). Cancer Lett 139: 159–165.
Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J et al. (1994). J Natl Cancer Inst 86: 695–699.
Xu HJ, Cagle PT, Hu SX, Li J, Benedict WF . (1996). Clin Cancer Res 2: 1169–1176.
Yamamoto Y, Shimizu E, Masuda N, Takada M, Sone S . (1998). Oncol Rep 5: 447–451.
Zamparelli A, Masciullo V, Bovicelli A, Santini D, Ferrandina G, Minimo C et al. (2001). Hum Pathol 32: 4–9.
Zhang B, Chen W, Roman A . (2006). Proc Natl Acad Sci USA 10: 437–442.
Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E et al. (2000). Blood 95: 1925–1930.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scambia, G., Lovergine, S. & Masciullo, V. RB family members as predictive and prognostic factors in human cancer. Oncogene 25, 5302–5308 (2006). https://doi.org/10.1038/sj.onc.1209620
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209620
Keywords
This article is cited by
-
E2F1: a promising regulator in ovarian carcinoma
Tumor Biology (2016)
-
Kaposi’s sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation
Oncogene (2014)
-
Novel anti-apoptotic effect of the retinoblastoma protein: implications for polyamine analogue toxicity
Amino Acids (2012)
-
Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency
Oncogene (2010)
-
Screening Genes Related to Development and Injury of the Mouse Optic Nerve by cDNA Microarrays
Cellular and Molecular Neurobiology (2010)